{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:13:02Z","timestamp":1759691582377,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"am","delay-in-days":251,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.addbeh.2021.106880","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T16:59:26Z","timestamp":1614099566000},"page":"106880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The impact of menthol cigarette use on quit attempts and abstinence among smokers with opioid use disorder"],"prefix":"10.1016","volume":"118","author":[{"given":"Danusha","family":"Selva Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghan","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenshu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pebbles","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadi","family":"Nahvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.addbeh.2021.106880_b0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12160-010-9252-y","article-title":"New Methods for Tobacco Dependence Treatment Research","volume":"41","author":"Baker","year":"2011","journal-title":"Annals of Behavioral Medicine"},{"key":"10.1016\/j.addbeh.2021.106880_b0010","doi-asserted-by":"crossref","unstructured":"Brunette, M. F., Ferron, J. C., Geiger, P., & Villanti, A. C. (2019). Menthol cigarette use in young adult smokers with severe mental illnesses. Nicotine and Tobacco Research, 21(5), 691-694.","DOI":"10.1093\/ntr\/nty064"},{"issue":"1","key":"10.1016\/j.addbeh.2021.106880_b0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/02791072.2018.1555651","article-title":"Relationship between Tobacco Use and Health-Related Quality of Life (HRQoL) among Clients in Substance Use Disorders Treatment","volume":"51","author":"Campbell","year":"2019","journal-title":"Journal of Psychoactive Drugs"},{"issue":"46","key":"10.1016\/j.addbeh.2021.106880_b0020","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.15585\/mmwr.mm6946a4","article-title":"Tobacco Product Use Among Adults \u2014 United States, 2019","volume":"69","author":"Cornelius","year":"2020","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"3","key":"10.1016\/j.addbeh.2021.106880_b0025","first-page":"341","article-title":"Ban on menthol-flavoured tobacco products predicts cigarette cessation at 1 year: A population cohort study","volume":"29","author":"Chaiton","year":"2020","journal-title":"Tobacco Control"},{"issue":"2","key":"10.1016\/j.addbeh.2021.106880_b0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.18001\/TRS.5.2.5","article-title":"Response to Reduced Nicotine Content in Vulnerable Populations: Effect of Menthol Status","volume":"5","author":"Davis","year":"2019","journal-title":"Tobacco Regulatory Science"},{"issue":"11","key":"10.1016\/j.addbeh.2021.106880_b0035","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/ntr\/ntu099","article-title":"Early Quit Days Among Methadone-Maintained Smokers in a Smoking Cessation Trial","volume":"16","author":"de Dios","year":"2014","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/j.addbeh.2021.106880_b0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1360-0443.2010.03190.x","article-title":"Nicotine dependence and quitting behaviors among menthol and non-menthol smokers with similar consumptive patterns","volume":"105","author":"Fagan","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2021.106880_b0045","series-title":"Menthol Cigarettes and Public Health: Review of the Scientific Evidence and Recommendations","first-page":"2011","author":"Food and Drug Administration","year":"2011"},{"key":"10.1016\/j.addbeh.2021.106880_b0050","unstructured":"Food and Drug Administration. (2013). Preliminary scientific evaluation of the possible public health effects of menthol versus nonmenthol cigarettes. Silver Spring, MD, 2013."},{"issue":"Supplement 2","key":"10.1016\/j.addbeh.2021.106880_b0055","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1093\/ntr\/ntq176","article-title":"Menthol Cigarettes: Moving Toward a Broader Definition of Harm","volume":"12","author":"Gardiner","year":"2010","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/j.addbeh.2021.106880_b0060","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.addbeh.2018.01.015","article-title":"Menthol cigarette smoking among individuals in treatment for substance use disorders","volume":"80","author":"Gubner","year":"2018","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.addbeh.2021.106880_b0065","doi-asserted-by":"crossref","unstructured":"Maani, N., Collin, J., Friel, S., Gilmore, A. B., McCambridge, J., Robertson, L., & Petticrew, M. P. (2020). Bringing the commercial determinants of health out of the shadows: a review of how the commercial determinants are represented in conceptual frameworks. European Journal of Public Health, 30(4), 660 - 664.","DOI":"10.1093\/eurpub\/ckz197"},{"key":"10.1016\/j.addbeh.2021.106880_b0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.healthplace.2018.06.011","article-title":"Disparities in retail marketing for menthol cigarettes in the United States, 2015","volume":"53","author":"Mills","year":"2018","journal-title":"Health & Place"},{"issue":"11","key":"10.1016\/j.addbeh.2021.106880_b0075","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.addbeh.2006.01.006","article-title":"Cigarette smoking and interest in quitting in methadone maintenance patients","volume":"31","author":"Nahvi","year":"2006","journal-title":"Addictive Behaviors"},{"issue":"9","key":"10.1016\/j.addbeh.2021.106880_b0080","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/add.12631","article-title":"Varenicline efficacy and safety among methadone maintained smokers: A randomized placebo-controlled trial: Varenicline RCT among methadone patients","volume":"109","author":"Nahvi","year":"2014","journal-title":"Addiction"},{"key":"10.1016\/j.addbeh.2021.106880_b0085","doi-asserted-by":"crossref","unstructured":"Nahvi, S., Adams, T. R., Ning, Y., Zhang, C., & Arnsten, J. H. (2020). Effect of varenicline directly observed therapy versus varenicline self-administered therapy on varenicline adherence and smoking cessation in methadone-maintained smokers: a randomized controlled trial. Addiction. [epub ahead of print] 10.1111\/add.15240.","DOI":"10.1111\/add.15240"},{"issue":"10","key":"10.1016\/j.addbeh.2021.106880_b0090","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.addbeh.2007.01.002","article-title":"Nicotine dependence among African American light smokers: A comparison of three scales","volume":"32","author":"Okuyemi","year":"2007","journal-title":"Addictive Behaviors"},{"issue":"2","key":"10.1016\/j.addbeh.2021.106880_b0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2105\/AJPH.91.2.296","article-title":"Tobacco use and quit attempts among methadone maintenance clients","volume":"91","author":"Richter","year":"2001","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.addbeh.2021.106880_b0100","doi-asserted-by":"crossref","unstructured":"Shah, P. A., Cunningham, C. O., Brisbane, M. T., DeLuca, J. P., & Nahvi, S. (2017). Use of smoking cessation methods among patients receiving office-based buprenorphine maintenance treatment. Journal of Addiction Medicine, 11(6), 494.","DOI":"10.1097\/ADM.0000000000000356"},{"issue":"5","key":"10.1016\/j.addbeh.2021.106880_b0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0924-9338(97)83297-X","article-title":"The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability","volume":"12","author":"Sheehan","year":"1997","journal-title":"European Psychiatry"},{"key":"10.1016\/j.addbeh.2021.106880_b0110","doi-asserted-by":"crossref","unstructured":"Shoptaw, S., Rotheram\u2010Fuller, E., Yang, X., Frosch, D., Nahom, D., Jarvik, M. E., ... & Ling, W. (2002). Smoking cessation in methadone maintenance. Addiction, 97(10), 1317-1328.","DOI":"10.1046\/j.1360-0443.2002.00221.x"},{"key":"10.1016\/j.addbeh.2021.106880_b0115","doi-asserted-by":"crossref","unstructured":"Smith, P. H., Assefa, B., Kainth, S., Salas-Ramirez, K. Y., McKee, S. A., & Giovino, G. A. (2020). Use of mentholated cigarettes and likelihood of smoking cessation in the United States: a meta-analysis. Nicotine and Tobacco Research, 22(3), 307-316.","DOI":"10.1093\/ntr\/ntz067"},{"issue":"2","key":"10.1016\/j.addbeh.2021.106880_b0120","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.drugalcdep.2013.07.005","article-title":"Varenicline for smoking cessation among methadone-maintained smokers: A randomized clinical trial","volume":"133","author":"Stein","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.addbeh.2021.106880_b0125","doi-asserted-by":"crossref","unstructured":"Trinidad, D. R., P\u00e9rez\u2010Stable, E. J., Messer, K., White, M. M., & Pierce, J. P. (2010). Menthol cigarettes and smoking cessation among racial\/ethnic groups in the United States. Addiction, 105, 84-94.","DOI":"10.1111\/j.1360-0443.2010.03187.x"},{"issue":"4","key":"10.1016\/j.addbeh.2021.106880_b0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40263-020-00701-z","article-title":"Achieving Smoking Cessation Among Persons with Opioid Use Disorder","volume":"34","author":"Vlad","year":"2020","journal-title":"CNS Drugs"},{"issue":"4","key":"10.1016\/j.addbeh.2021.106880_b0135","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/add.14082","article-title":"Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: Emerging disparities in vulnerable populations: Cigarette use and substance use disorders","volume":"113","author":"Weinberger","year":"2018","journal-title":"Addiction"}],"container-title":["Addictive Behaviors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460321000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306460321000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T18:44:17Z","timestamp":1759689857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306460321000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":27,"alternative-id":["S0306460321000654"],"URL":"https:\/\/doi.org\/10.1016\/j.addbeh.2021.106880","relation":{},"ISSN":["0306-4603"],"issn-type":[{"type":"print","value":"0306-4603"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of menthol cigarette use on quit attempts and abstinence among smokers with opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addbeh.2021.106880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106880"}}